Zahra Masoud, Author at Neurology Advisor

Stroke and COVID-19: A Multicenter Cross-Sectional Study

By

Zahra Masoud

December 11, 2020

COVID-19 as a cause of increased risk of stroke was assessed by research authors, who compiled discharge data from electronic medical records from 6 stroke facilities in New York.

The approval is based on evidence that the vaccine can prevent anogenital infections, with an ongoing trial looking at throat infection prevention in men likely to be critical for continued approval.

Neurodegenerative Diseases

Influenza Vaccination Does Not Increase Risk for Guillain-Barré Syndrome

By

Zahra Masoud

December 3, 2020

Study authors identified and evaluated a statistical signal for an increased risk of Guillain-Barré Syndrome in days 1-42 after 2018-2019 high-dose influenza vaccine administration.

General Neurology

Social Distancing: Timing and Adherence Impact COVID-19 Cases

By

Zahra Masoud

December 2, 2020

Researchers sought to determine the effect of social distancing measures in Dane County, Wisconsin, the Milwaukee metropolitan area, and the New York City metropolitan area.

General Neurology

SARS-CoV-2 Associated With a Spectrum of Encephalitis

By

Zahra Masoud

November 17, 2020

SARS-CoV-2’s association with encephalitis was assessed by authors, taking varying clinical presentations, responses to treatment, and outcomes into account.

Neurobehavioral Disorders

Discontinuation of Dolutegravir Due to Neurologic Side Effects Linked to Pre-Existing Mental Illness

By

Zahra Masoud

April 6, 2020

Dolutegravir (DTG) discontinuation due to neuropsychologic side effects (NPS) may be associated with pre-existing psychiatric conditions of depression and anxiety.

Meningococcal Vaccine Syringe With Yellow Vaccine

General Neurology

Meningococcal B Vaccine Does Not Affect Carriage

By

Zahra Masoud

February 19, 2020

4CMedB, a new multi-antigen vaccine designed to control group B meningococcal disease, had no effect on carriage of disease-causing meningococci in adolescents.